| Net income | -1.68M |
| Depreciation and amortization | 936K |
| Share-based compensation | 264K |
| Amortization of deferred gain | |
| Amortization of debt issuance costs | 136K |
| Reversal of deferred tax asset valuation allowance | |
| Excess tax benefits related to share-based compensation | |
| Other | |
| Accounts receivable | 2M |
| Inventories | 385K |
| Other current assets | |
| Other assets | -37K |
| Accounts payable and accrued expenses | |
| Income taxes payable | 859K |
| Net cash flows provided by operating activities | |
| Purchase of property and equipment | -244K |
| Decrease (increase) in restricted cash | |
| Proceeds from sale of property and equipment | 0 |
| Consolidation of ARCA Advanced Processing (AAP) | |
| Net cash flows used in investing activities | |
| Checks issued in excess of cash in bank | |
| Net borrowings (payments) under line of credit | -2.86M |
| Payments on debt obligations | -821K |
| Proceeds from issuance of debt obligations | 100K |
| Proceeds from issuance of Common Stock, net of offering costs | 0 |
| Payment of debt issuance costs | -125K |
| Excess tax benefits related to share-based compensation | |
| Net cash flows provided by (used in) financing activities | |
| Effect of changes in exchange rate on cash and cash equivalents | |
| Increase in cash and cash equivalents | -260K |
| Cash and cash equivalents at beginning of period | 1.97M |
| Cash and cash equivalents at end of period | 1.71M |
| Cash payments for interest | |
| Cash payments for income taxes | 860K |
| Loan receivable exchanged for equity in AAP | |
| Equipment acquired under capital leases | |
| Fair value of assets acquired | |
| Assumed liabilities | |